CGTX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Cognition Therapeutics Inc (CGTX) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available for investment. The lack of significant positive catalysts, poor financial performance, and absence of strong trading signals suggest that holding off on this stock is a more prudent decision.
The MACD is positive and expanding, indicating a bullish momentum. However, the RSI at 75.393 is in the neutral zone, and moving averages are converging, which does not provide a clear directional signal. The stock is trading near its resistance levels (R1: 1.083, R2: 1.173), suggesting limited upside potential in the short term.
The MACD shows positive momentum, which could indicate short-term bullishness.
No significant news, hedge fund, or insider trading activity. Financials show declining net income and EPS. Stock trend analysis indicates limited growth potential in the short term.
In Q4 2025, revenue remained at 0 with no growth YoY. Net income dropped by -57.37% YoY to -$3,343,000, and EPS fell by -77.78% YoY to -0.04. Gross margin remained at 0 with no improvement.
No analyst rating or price target changes available.
